Stereotactic Ablative Radiotherapy as a Tool in Renal Cell Carcinoma for Building RAPPORT with Systemic Therapy

Eur Urol. 2022 Apr;81(4):373-374. doi: 10.1016/j.eururo.2022.01.001. Epub 2022 Jan 19.

Authors

Carole Mercier¹, Michiel Strijbos², Piet Ost³

Affiliations

¹ Iridium Network, Radiation Oncology, Antwerp, Belgium; Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium. Electronic address: [email protected].
² Department of Medical Oncology, GZA Sint-Augustinus, Antwerp, Belgium.
³ Iridium Network, Radiation Oncology, Antwerp, Belgium; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.

PMID: 35063309
DOI: 10.1016/j.eururo.2022.01.001

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Renal Cell* / radiotherapy
Carcinoma, Renal Cell* / surgery
Female
Humans
Kidney Neoplasms* / pathology
Male
Radiosurgery*